Climb Bio, Inc.
CLYM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768446
In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 2 sales; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Climb Bio, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −2 vs. Q3 2022
- Shares held
- 16.6M
- +1.82M (+12.3%) vs. Q3 2022
- Total value
- $61.0M
- +$13.2M (+27.6%) vs. Q3 2022
- New holders
- 2
- 7 more added
- Sold out
- 4
- 6 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLYM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 108 | $734.3M |
| Q1 2026 | 80 | $221.2M |
| Q4 2025 | 65 | $157.4M |
| Q3 2025 | 68 | $89.7M |
| Q2 2025 | 69 | $61.9M |
| Q1 2025 | 76 | $63.4M |
| Q4 2024 | 80 | $100.3M |
| Q3 2024 | 71 | $278.2M |
| Q2 2024 | 47 | $354.8M |
| Q1 2024 | 21 | $46.2M |
| Q4 2023 | 23 | $45.5M |
| Q3 2023 | 23 | $44.0M |
| Q2 2023 | 22 | $46.8M |
| Q1 2023 | 19 | $48.4M |
| Q4 2022 | 20 | $61.0M |
| Q3 2022 | 22 | $47.8M |
| Q2 2022 | 29 | $45.7M |
| Q1 2022 | 43 | $146.8M |
| Q4 2021 | 35 | $181.8M |
| Q3 2021 | 32 | $310.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Climb Bio, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 13,150,849 | $48.3M | 0.98% | 00.0% | Unchanged |
| BML Capital Management, LLC | 1,825,134 | $6.70M | 6.40% | +1,825,134 | New |
| Driehaus Capital Management LLC | 551,942 | $2.03M | 0.03% | +203,371+58.3% | Added |
| Silverarc Capital Management, LLC | 409,202 | $1.50M | 0.52% | +7,114+1.8% | Added |
| Vanguard Group Inc | 274,517 | $1.01M | 0.00% | +1250.0% | Added |
| Atom Investors LP | 75,651 | $277.6K | 0.14% | +8,577+12.8% | Added |
| Millennium Management LLC | 67,685 | $242.0K | 0.00% | −4,380−6.1% | Reduced |
| Geode Capital Management, LLC | 64,014 | $229.0K | 0.00% | −125−0.2% | Reduced |
| Bridgeway Capital Management, LLC | 55,223 | $197.7K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 32,203 | $118.2K | 0.00% | +332+1.0% | Added |
| Tudor Investment Corp Et Al | 30,607 | $112.0K | 0.00% | −120.0% | Reduced |
| Bank of Montreal | 25,244 | $92.6K | 0.00% | +25,244 | New |
| State Street Corp | 19,800 | $70.9K | 0.00% | 00.0% | Unchanged |
| Chicago Partners Investment Group LLC | 18,179 | $61.9K | 0.00% | 00.0% | Unchanged |
| Stifel Financial Corp | 14,862 | $54.5K | 0.00% | −1,300−8.0% | Reduced |
| Northern Trust Corp | 11,494 | $42.2K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 699 | $2.56K | 0.00% | +3+0.4% | Added |
| Tower Research Capital LLC (TRC) | 642 | $2.00K | 0.00% | −339−34.6% | Reduced |
| Morgan Stanley | 145 | $532 | 0.00% | −4,622−97.0% | Reduced |
| Wells Fargo & Company | 42 | $154 | 0.00% | +1+2.4% | Added |
| Woodline Partners LP | 0 | $0 | 0.00% | −226,604−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,587−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −158−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −111−100.0% | Sold out |